(Q38038901)

27 August 2017

title

Insights into bone marrow-derived mesenchymal stem cells safety for cutaneous repair and regeneration (English)

1 reference

27 August 2017

main subject

mesenchymal stem cell

1 reference

Y Wu

1

1 reference

27 August 2017

S Huang

series ordinal

2

1 reference

27 August 2017

J Enhe

series ordinal

3

1 reference

27 August 2017

X Fu

series ordinal

4

1 reference

27 August 2017

language of work or name

1 reference

30 August 2012

1 reference

International Wound Journal

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

586-594

1 reference

Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

In vitro differentiation of human mesenchymal stem cells to epithelial lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Bone marrow-derived stem cells in wound healing: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Mesenchymal stem cells as trophic mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Isolation and expansion of mesenchymal stem cells/multipotential stromal cells from human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Infrastructure development for human cell therapy translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Bioprocessing of embryonic stem cells for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Human embryonic stem cells express an immunogenic nonhuman sialic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned med

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Developing safe therapies from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Mesenchymal stem cells as therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Banking on it: public policy and the ethics of stem cell research and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Mesenchymal stem cells in arthritic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2012.01076.X

10.1111/J.1742-481X.2012.01076.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference